Cervical Cancer-Market Insights, Epidemiology and Market Forecast-2023- EU5

Publisher Name :
Date: 01-Jan-2017
No. of pages: 60
Price : Single User: US $ 2450  US $ 2083 Corporate User: US $ 7350  US $ 5145
This report is available at 15% Discount for Single User License and 30% Discount for Corporate Users License till 30 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Cervical Cancer- Market Insights, Epidemiology and Market Forecast-2023- EU5" Report provides marketed drugs information of Cervical Cancer. It has included historical and forecasted epidemiology and market size of the Cervical Cancer for Europe (Germany, Spain, France, Italy and United Kingdom) for 2013-2023. DelveInsight estimates that the therapeutic market size of Cervical Cancer in European (EU5) market is expected to grow at a Compound Annual Growth Rate of 0.019% and reach up to USD 109.8 million by 2023. The global market size of prophylaxis treatment for Cervical Cancer is expected to grow at a Compound Annual Growth Rate of 0.71% and reach up to USD 2210.9 Million by 2023.

Cervical Cancer needs to be focused more and more because it adversely affects younger women. It is the fourth most common cause of death among women. Cervical Cancer occurs due to the uncontrolled growth of healthy cells in cervix and forms cervical lesions. It spreads to other tissues such as vagina and uterus. Cervical Cancer is caused by inheritance of defects or mutation in genes. Cervical cancer is also caused due to the infection by the Human Papilloma Virus (HPV) which can infect cells on the surface of the skin and those lining the genitals, anus, mouth and throat, but not the blood or internal organs such as the heart or lungs.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

• Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

• Marketed information including available prescription drugs, its patent and exclusivity details.

• The Report also covers the detailed global historical and forecasted epidemiological data for EU5 (France, Germany, Italy, Spain and UK) from 2013-2023.

• It also provides Market size of Cervical Cancer for EU5 (France, Germany, Italy, Spain and UK from 2013 and forecasted Market size to 2023.

• The report will help in developing business strategies by understanding the trends shaping and driving the EU5 (France, Germany, Italy, Spain and UK) market size of the Cervical Cancer

• Identifying patient populations in the EU5 (France, Germany, Italy, Spain and UK) Cervical Cancer market to improve product design, pricing, and launch plans.

• To understand the future market competition in EU5 (France, Germany, Italy, Spain and UK), Cervical Cancer therapeutics market, as well as prophylaxis and Insightful review of the key market drivers and barriers.

This report is available at 15% Discount for Single User License and 30% Discount for Corporate Users License till 30 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Cervical Cancer-Market Insights, Epidemiology and Market Forecast-2023- EU5

Table of Contents

Report Introduction
Cervical Cancer Disease Overview
Types of Cervical Cancer
Staging of Cervical Cancer
Pathophysiology
Etiology
Risk Factors of Cervical Cancer
Diagnosis of Cervical Cancer
Epidemiology and Patient Population of Cervical Cancer
United Kingdom (UK)
Historical Incident Cases of Cervical Cancer in United Kingdom (UK) (2013-2015)
Forecasted Incident Cases of Cervical Cancer in United Kingdom (UK) (2016-2023)
Germany (GE)
Historical Incident Cases of Cervical Cancer in Germany (GE) (2013-2015)
Forecasted Incident Cases of Cervical Cancer in Germany (GE) (2016-2023)
Italy (IT)
Historical Incident Cases of Cervical Cancer in Italy (IT) (2013-2015)
Forecasted Incident Cases of Cervical Cancer in Italy (IT) (2016-2023)
France (FR)
Historical Incident Cases of Cervical Cancer in France (FR) (2013-2015)
Forecasted Incident Cases of Cervical Cancer in France (FR) (2016-2023)
Spain (SP)
Historical Incident Cases of Cervical Cancer in Spain (SP) (2013-2015)
Forecasted Incident Cases of Cervical Cancer in Spain (SP) (2016-2023)
Treatment Landscape
Treatment Algorithm
Treatment by Stages
Cervical Cancer Treatment Regimens
Current Unmet Needs
Cervical Cancer Emerging therapies Market Size
a) Bevacizumab (Avastin)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
Avastin Historical Market Sales 2013-2015
Cost of therapy of Avastin
Cervical Cancer Prophylaxis Treatments
a) Cervarix (Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
Cervarix Historical Market Sales 2012-2015
Cost of therapy of Cervarix
b) Gardasil/ Gardasil 9
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
Gardasil Historical Market Sales 2012-2015
Cost of therapy of Gardasil
Pipeline Product (Phase III)
a) Z-100 (Ancer 20)
b) Axalimogene filolisbac or AXAL (ADXS11-001)
c) Gimeracil-Oteracil-Tegafur (S-1, TS-1)
Pipeline Product Analysis
Cervical Cancer Therapeutics Market in Europe5
Historical market size of United Kingdom (UK) (2013-2015)
Forecasted market size of United Kingdom (UK) (2016-2023)
Historical market size of Germany (GE) (2013-2015)
Forecasted market size of Germany (GE) (2016-2023)
Historical market size of Italy (IT) (2013-2015)
Forecasted market size of Italy (IT) (2016-2023)
Historical market size of France (FR) (2013-2015)
Forecasted market size of France (FR) (2016-2023)
Historical market size of Spain (SP) (2013-2015)
Forecasted market size of Spain (SP)(2016-2023)
Cervical Cancer Prophylaxis Treatment Global
Historical Prophylaxis treatment market size (2013-2015)
Forecasted Prophylaxistreatment market size (2016-2023)
Market Drivers
Market Barriers
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1: Historical Incident Cases of Cervical Cancer in United Kingdom (UK) (2013-2015)
Table 2: Forecasted Incident Cases of Cervical Cancer in United Kingdom (UK) (2017-2023)
Table 3: Historical Incident Cases of Cervical Cancer in Germany (2013-2015)
Table 4: Forecasted Incident Cases of Cervical Cancer in Germany (2017-2023)
Table 5:Historical Incident Cases of Cervical Cancer in Italy (2013-2015)
Table 6: Forecasted Incident Cases of Cervical Cancer in Italy (2017-2023)
Table 7: Historical Incident Cases of Cervical Cancer in France (2013-2015)
Table 8: Forecasted Incident Cases of Cervical Cancer in France (2017-2023)
Table 9: Historical Incident Cases of Cervical Cancer in Spain (2013-2015)
Table 10: Forecasted Incident Cases of Cervical Cancer in Spain (2017-2023)
Table 11: Historical Cervical Cancer Therapeutics Market in United Kingdom (2013-2015)
Table 12: Forecasted Cervical Cancer Therapeutics Market in United Kingdom (2017-2023)
Table 13: Historical Cervical Cancer Therapeutics Market in Germany (2013-2015)
Table 14: Forecasted Cervical Cancer Therapeutics Market in Germany (2017-2023)
Table 15: Historical Cervical Cancer Therapeutics Market in Italy (2013-2015)
Table 16: Forecasted Cervical Cancer Therapeutics Market in Italy (2017-2023)
Table 17: Historical Cervical Cancer Therapeutics Market in France (2013-2015)
Table 18: Forecasted Cervical Cancer Therapeutics Market in France (2017-2023)
Table 19: Historical Cervical Cancer Therapeutics Market in Spain (2013-2015)
Table 20: Forecasted Cervical Cancer Therapeutics Market in Spain (2017-2023)
Table 21: Historical Cervical Cancer prophylaxis treatment global (2013-2015)
Table 21: Forecasted Cervical Cancer prophylaxis treatment global (2017-2023)

List of Figures

Figure 1: Pathophysiology of Cervical Cancer, 2017
Figure 2:Risk Factors of Cervical Cancer, 2017
Figure 3: Historical Incident Cases of Cervical Cancer in United Kingdom (UK) (2013-2015)
Figure 4: Forecasted Incident Cases of Cervical Cancer in United Kingdom (UK) (2017-2023)
Figure 5: Historical Incident Cases of Cervical Cancer in Germany (2013-2015)
Figure 6: Forecasted Incident Cases of Cervical Cancer in Germany (2017-2023)
Figure7:Historical Incident Cases of Cervical Cancer inItaly (2013-2015)
Figure8: Forecasted Incident Cases of Cervical Cancer in Italy (2017-2023)
Figure9: Historical Incident Cases of Cervical Cancer in France (2013-2015)
Figure10: Forecasted Incident Cases of Cervical Cancer in France (2017-2023)
Figure 11: Historical Incident Cases of Cervical Cancer in Spain (2013-2015)
Figure 12: Forecasted Incident Cases of Cervical Cancer in Spain (2017-2023)
Figure 13:Treatment Algorithm for Cervical Cancer, 2017
Figure 14:Treatment for patients with Stage IA1 of Cervical Cancer, 2017
Figure 15:Treatment for patients with Stage IA2 of Cervical Cancer, 2017
Figure 16:Treatment for patients with Stage IB1 of Cervical Cancer, 2017
Figure 17:Treatment for patients with Stage IB2 to Stage IVA of Cervical Cancer, 2017
Figure 18:Treatment for patients with Stage IVB of Cervical Cancer, 2017
Figure19: Historical Cervical Cancer Therapeutics Market in United Kingdom (2013-2015)
Figure20: Forecasted Cervical Cancer Therapeutics Market in United Kingdom (2017-2023)
Figure21: Historical Cervical Cancer Therapeutics Market in Germany (2013-2015)
Figure22: Forecasted Cervical Cancer Therapeutics Market in Germany (2017-2023)
Figure 23: Historical Cervical Cancer Therapeutics Market in Italy (2013-2015)
Figure24: Forecasted Cervical Cancer Therapeutics Market in Italy (2017-2023)
Figure25: Historical Cervical Cancer Therapeutics Market in France (2013-2015)
Figure 26: Forecasted Cervical Cancer Therapeutics Market in France (2017-2023)
Figure27: Historical Cervical Cancer Therapeutics Market in Spain (2013-2015)
Figure 28: Forecasted Cervical Cancer Therapeutics Market in Spain (2017-2023)
Figure29: Historical Cervical Cancer prophylaxis treatment global (2013-2015)
Figure30: Forecasted Cervical Cancer prophylaxis treatment global (2017-2023)
  • EMEA (Europe, Middle East and Africa) Capecitabine Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the EMEA Capecitabine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Capecitabine for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle......
  • Europe Topotecan Hydrochloride Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 26-Jun-2017        Price: US 4480 Onwards        Pages: 124
    Topotecan Hydrochloride is the hydrochloride salt of a semisynthetic derivative of camptothecin with antineoplastic activity. During the S phase of the cell cycle, topotecan selectively stabilizes topoisomerase I-DNA covalent complexes, inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when complexes are encountered by the DNA replication machinery. Camptothecin is a cytotoxic quinoline-based alkaloid extracted fr......
  • Global Megestrol Market Research Report 2017
    Published: 23-Jun-2017        Price: US 2900 Onwards        Pages: 117
    In this report, the global Megestrol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Megestrol in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan - ......
  • Asia-Pacific Mitomycin C Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 22-Jun-2017        Price: US 4480 Onwards        Pages: 116
    This report studies the Mitomycin C market, Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.). Scope of the Report: This report focuses on the Mitomycin C in Asia-Pacific market, especially in Ch......
  • United States Capecitabine Market Report 2017
    Published: 20-Jun-2017        Price: US 3800 Onwards        Pages: 102
    In this report, the United States Capecitabine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Cap......
  • Asia-Pacific Paclitaxel Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 20-Jun-2017        Price: US 4480 Onwards        Pages: 123
    Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol". Scope of the Report: This report focuses on the Paclitaxel in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes......
  • Global Capecitabine Sales Market Report 2017
    Published: 14-Jun-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the global Capecitabine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Capecitabine for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Sou......
  • Global Paclitaxel Injection Market Professional Survey Report 2017
    Published: 14-Jun-2017        Price: US 3500 Onwards        Pages: 117
    This report studies Paclitaxel Injection in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Bristol-Myers Squibb - Celgene Corporation - Hospira - Biologic......
  • Global Lymphoma Drugs Market 2017-2021
    Published: 07-Jun-2017        Price: US 3500 Onwards        Pages: 86
    Lymphoma is a type of cancer that affects the immune system of the body. Specifically, it affects the lymphocytes, a type of white blood cell. The lymphocytes are part of the immune system and help the body to fight infections. The cancerous lymphocytes grow uncontrollably and collect in different portions of the body; lymph node can be one of the most common sites for lymphoma development. The lymph nodes are found throughout the body particularly in the groin, neck, and under the arms. Lymp......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs